2019 Q1 Form 10-Q Financial Statement

#000156459019016628 Filed on May 07, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $21.97M $13.56M
YoY Change 61.97% 93.61%
Cost Of Revenue $8.430M $7.330M
YoY Change 15.01% 98.43%
Gross Profit $13.53M $6.234M
YoY Change 117.04% 88.22%
Gross Profit Margin 61.58% 45.96%
Selling, General & Admin $16.16M $13.61M
YoY Change 18.77% -0.56%
% of Gross Profit 119.45% 218.27%
Research & Development $13.44M $9.437M
YoY Change 42.42% 3.14%
% of Gross Profit 99.33% 151.38%
Depreciation & Amortization $376.0K $413.0K
YoY Change -8.96% -11.94%
% of Gross Profit 2.78% 6.62%
Operating Expenses $29.60M $23.04M
YoY Change 28.45% 0.92%
Operating Profit -$16.07M -$13.36M
YoY Change 20.34% -26.19%
Interest Expense -$3.090M $915.0K
YoY Change -437.7% 72.32%
% of Operating Profit
Other Income/Expense, Net $420.0K -$476.0K
YoY Change -188.24% 1.28%
Pretax Income -$18.73M -$13.83M
YoY Change 35.42% -25.49%
Income Tax $60.00K $54.00K
% Of Pretax Income
Net Earnings -$18.79M -$13.89M
YoY Change 35.34% -25.34%
Net Earnings / Revenue -85.53% -102.37%
Basic Earnings Per Share -$0.14 -$0.11
Diluted Earnings Per Share -$0.14 -$0.11
COMMON SHARES
Basic Shares Outstanding 124.8M
Diluted Shares Outstanding 124.8M

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.4M $105.9M
YoY Change -5.19% 96.84%
Cash & Equivalents $31.73M $17.69M
Short-Term Investments $71.40M $91.00M
Other Short-Term Assets $5.000M $4.300M
YoY Change 16.28% 24.24%
Inventory $15.80M $13.20M
Prepaid Expenses
Receivables $13.80M $10.50M
Other Receivables $0.00 $0.00
Total Short-Term Assets $134.9M $133.8M
YoY Change 0.82% 76.7%
LONG-TERM ASSETS
Property, Plant & Equipment $31.70M $2.000M
YoY Change 1485.0% -29.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.700M $6.900M
YoY Change 11.59% 67.76%
Total Long-Term Assets $41.00M $10.60M
YoY Change 286.79% 14.95%
TOTAL ASSETS
Total Short-Term Assets $134.9M $133.8M
Total Long-Term Assets $41.00M $10.60M
Total Assets $175.9M $144.4M
YoY Change 21.81% 70.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.90M $11.20M
YoY Change 86.61% 27.43%
Accrued Expenses $20.00M $9.700M
YoY Change 106.19% 2.19%
Deferred Revenue $763.0K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $1.400M
YoY Change -100.0% -81.82%
Total Short-Term Liabilities $47.59M $23.70M
YoY Change 100.82% -10.38%
LONG-TERM LIABILITIES
Long-Term Debt $39.40M $28.40M
YoY Change 38.73% 170.48%
Other Long-Term Liabilities $88.00K $6.800M
YoY Change -98.71% 319.24%
Total Long-Term Liabilities $88.00K $35.20M
YoY Change -99.75% 2070.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $47.59M $23.70M
Total Long-Term Liabilities $88.00K $35.20M
Total Liabilities $106.4M $58.80M
YoY Change 81.0% 35.32%
SHAREHOLDERS EQUITY
Retained Earnings -$797.7M
YoY Change
Common Stock $867.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $69.50M $85.60M
YoY Change
Total Liabilities & Shareholders Equity $175.9M $144.4M
YoY Change 21.83% 70.0%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$18.79M -$13.89M
YoY Change 35.34% -25.34%
Depreciation, Depletion And Amortization $376.0K $413.0K
YoY Change -8.96% -11.94%
Cash From Operating Activities -$22.18M -$10.33M
YoY Change 114.8% -36.85%
INVESTING ACTIVITIES
Capital Expenditures $3.315M $52.00K
YoY Change 6275.0% -71.89%
Acquisitions
YoY Change
Other Investing Activities $16.50M -$44.69M
YoY Change -136.92% -862.63%
Cash From Investing Activities $13.19M -$44.74M
YoY Change -129.47% -887.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $57.56M
YoY Change
Debt Paid & Issued, Net $31.01M $32.00K
YoY Change 96806.25% -97.48%
Cash From Financing Activities 9.133M 58.83M
YoY Change -84.47% -6784.89%
NET CHANGE
Cash From Operating Activities -22.18M -10.33M
Cash From Investing Activities 13.19M -44.74M
Cash From Financing Activities 9.133M 58.83M
Net Change In Cash 140.0K 3.759M
YoY Change -96.28% -132.55%
FREE CASH FLOW
Cash From Operating Activities -$22.18M -$10.33M
Capital Expenditures $3.315M $52.00K
Free Cash Flow -$25.49M -$10.38M
YoY Change 145.67% -37.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-329000
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4958000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7034000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15631000
CY2018Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
7857000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1560000
CY2019Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
763000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
498000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
47594000
CY2019Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
39433000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19311000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
88000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4250000
CY2019Q1 us-gaap Liabilities
Liabilities
106426000
CY2018Q4 us-gaap Liabilities
Liabilities
78941000
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
138000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
136000
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
867091000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
863531000
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-70000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-281000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-797659000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-778867000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
69500000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
84519000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
175926000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
163460000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5004000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1926000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2286000
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1224000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2165000
CY2018Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1475000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2597000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-122000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124814000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-329000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14214000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
211000
CY2019Q1 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Vesting Of Restricted Stock Units And Employee Stock Purchase Plans Purchases Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndVestingOfRestrictedStockUnitsAndEmployeeStockPurchasePlansPurchasesValue
684000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2878000
CY2019Q1 cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
-4809000
CY2018Q1 cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
-1340000
CY2019Q1 cers Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
-118000
CY2018Q1 cers Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
164000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
265000
CY2018Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
186000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22178000
CY2019Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
13440000
CY2018Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
9437000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16161000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13607000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
23044000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13355000
CY2018Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
108000
CY2018Q1 us-gaap Interest Expense
InterestExpense
915000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
331000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-476000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13831000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-13885000
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124814000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
38940000
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
57262000
CY2018Q1 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Vesting Of Restricted Stock Units And Employee Stock Purchase Plans Purchases Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndVestingOfRestrictedStockUnitsAndEmployeeStockPurchasePlansPurchasesValue
1295000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2315000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
85598000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-18792000
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-13885000
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
413000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2315000
CY2019Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
31010000
CY2018Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
32000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9133000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58827000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
140000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3759000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31587000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13930000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10325000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3315000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
52000
CY2019Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1000000
CY2018Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
56941000
CY2019Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
17500000
CY2018Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
12250000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13185000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44743000
CY2019Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
710000
CY2018Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1295000
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
57564000
CY2019Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
39433000
CY2019Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
75571000
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, including those related to the nature and timing of satisfaction of performance obligations, the timing when the customer obtains control of products or services, the standalone selling price (&#8220;SSP&#8221;) of performance obligations, variable consideration, accounts receivable, inventory reserves, fair values of investments, stock-based compensation, intangible assets and goodwill, useful lives of intangible assets and property and equipment, income taxes, accrued liabilities, and incremental borrowing rate, among others. The Company bases its estimates on historical experience, future projections, and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p>
CY2019Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, available-for-sale securities and accounts receivable.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the Company&#8217;s investment policy, substantially all of the Company&#8217;s cash, cash equivalents and available-for-sale securities are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company&#8217;s investments carry high credit quality ratings, which is in accordance with its investment policy. At March&#160;31, 2019, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company&#8217;s cash equivalents and short-term investments.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of credit risk with respect to trade receivables exist. On a regular basis, including at the time of sale, the Company performs credit evaluations of its significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its unaudited condensed consolidated balance sheets and records a charge on its unaudited condensed consolidated statements of operations as a component of selling, general and administrative expenses.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company had three and two customers that accounted for more than 10% of the Company&#8217;s outstanding trade receivables at March&#160;31, 2019 and December&#160;31, 2018, respectively. These customers cumulatively represented approximately 59% and 50% of the Company&#8217;s outstanding trade receivables at March&#160;31, 2019 and December&#160;31, 2018, respectively. To date, the Company has not experienced collection difficulties from these customers.</p>
CY2019Q1 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Guarantee and Indemnification Arrangements</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company&#8217;s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company&#8217;s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable. The Company has not experienced significant or systemic warranty claims nor is it aware of any existing current warranty claims. Accordingly, the Company had not accrued for any future warranty costs for its products at March&#160;31, 2019 and December&#160;31, 2018.</p>
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19902000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19550000
CY2019Q1 cers Product Warranty Term
ProductWarrantyTerm
P1Y
CY2019Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2018Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2019Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
75641000
CY2019Q1 us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
The Company invoices its customers based upon the terms in the contracts, which is generally from 30 to 60 days.
CY2019Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2018Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000
CY2019Q1 us-gaap Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
true
CY2019Q1 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
3
CY2018Q4 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
2
CY2019Q1 cers Work In Process Inventory Life Period
WorkInProcessInventoryLifePeriod
P1Y
CY2019Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
400000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
300000
CY2019Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1700000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1700000
CY2019Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P10Y
CY2019Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2018Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2019Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
18000
CY2019Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
88000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Principal Interest And Fees In Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFeesInRemainderOfFiscalYear
2250000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
95166000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
283000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
94885000
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
75641000
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
85227000
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
9939000
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
75571000
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
84957000
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
9928000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
75761000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
253000
CY2019Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
54956000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
10975000
CY2019Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
88000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
30000
CY2019Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
54956000
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
86736000
CY2019Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
88000
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
283000
CY2019Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2018Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2019Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
CY2018Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
CY2019Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2018Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2019Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4342000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3075000
CY2019Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11436000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10464000
CY2019Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
8323000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4544000
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6490000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10765000
CY2019Q1 cers Accrued Development Costs Current
AccruedDevelopmentCostsCurrent
1908000
CY2018Q4 cers Accrued Development Costs Current
AccruedDevelopmentCostsCurrent
1965000
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1676000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2526000
CY2019Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
15000000
CY2019Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
20000000
CY2019Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
5000000
CY2019Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
40000000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Interest And Fees In Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfInterestAndFeesInRemainderOfFiscalYear
2250000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Interest And Fees In Year Two
LongTermDebtMaturitiesRepaymentsOfInterestAndFeesInYearTwo
3335000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Interest And Fees In Year Three
LongTermDebtMaturitiesRepaymentsOfInterestAndFeesInYearThree
3326000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Interest And Fees In Year Four
LongTermDebtMaturitiesRepaymentsOfInterestAndFeesInYearFour
2909000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Interest And Fees In Year Five
LongTermDebtMaturitiesRepaymentsOfInterestAndFeesInYearFive
1315000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Interest And Fees In Year Six
LongTermDebtMaturitiesRepaymentsOfInterestAndFeesInYearSix
1270000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Interest And Fees
LongTermDebtMaturitiesRepaymentsOfInterestAndFees
14405000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Principal Interest And Fees In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFeesInYearTwo
3335000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Principal Interest And Fees In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFeesInYearThree
3326000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Principal Interest And Fees In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFeesInYearFour
17909000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Principal Interest And Fees In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFeesInYearFive
21315000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Principal Interest And Fees In Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFeesInYearSix
6270000
CY2019Q1 cers Long Term Debt Maturities Repayments Of Principal Interest And Fees
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFees
54405000
CY2019Q1 cers Minimum Term Of Non Cancelable Operating Leases
MinimumTermOfNonCancelableOperatingLeases
P1Y
CY2019Q1 cers Expiration Of Non Cancelable Operating Leases Maximum Year
ExpirationOfNonCancelableOperatingLeasesMaximumYear
2030
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
734000
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13560000
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y10M24D
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.090
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2796000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3047000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3086000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2714000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2610000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
18690000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
32943000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12072000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
20871000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
500000
CY2018Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
300000
CY2019Q1 us-gaap Lessor Operating Lease Lease Not Yet Commenced Description
LessorOperatingLeaseLeaseNotYetCommencedDescription
the Company had no leases that have not yet commenced.
CY2019Q1 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
7800000
CY2018Q1 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
5400000
CY2019Q1 cers Accrual For Manufacturing Of Entity Products
AccrualForManufacturingOfEntityProducts
7507000
CY2018Q4 cers Accrual For Manufacturing Of Entity Products
AccrualForManufacturingOfEntityProducts
7812000
CY2019Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
954000
CY2018Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
1777000
CY2019Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001564590-19-016628-index-headers.html Edgar Link pending
0001564590-19-016628-index.html Edgar Link pending
0001564590-19-016628.txt Edgar Link pending
0001564590-19-016628-xbrl.zip Edgar Link pending
cers-10q_20190331.htm Edgar Link pending
cers-20190331.xml Edgar Link completed
cers-20190331.xsd Edgar Link pending
cers-20190331_cal.xml Edgar Link unprocessable
cers-20190331_def.xml Edgar Link unprocessable
cers-20190331_lab.xml Edgar Link unprocessable
cers-20190331_pre.xml Edgar Link unprocessable
cers-ex101_163.htm Edgar Link pending
cers-ex102_164.htm Edgar Link pending
cers-ex103_124.htm Edgar Link pending
cers-ex311_8.htm Edgar Link pending
cers-ex312_9.htm Edgar Link pending
cers-ex321_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gmvbzzxs50cq000001.jpg Edgar Link pending
gtuhnapxwjyz000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending